$5.870
+0.030 (+0.51%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
CV 相似圖表分析預測
Alphio's CV stock price prediction model matches the current CapsoVision Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.78 (-1.56%). The 1-week path is $5.77 (-1.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 CapsoVision Inc 股票嗎?
CapsoVision Inc is a good buy right now, trading at $5.93 with a forward P/E of 0 and a gross margin of 51.36%. The recent 10% revenue growth in Q2 2026 and the positive analyst ratings suggest strong potential for recovery and growth. However, the main risk is the net income loss of $7.48 million in Q2 2026, which indicates ongoing financial challenges.
CV 股價於 Tuesday 收在 $5.87,此前上漲 +0.51%
CapsoVision Inc (CV) last closed at $5.87, gaining +0.51%. These facts feed the 1-day and 1-week CV price prediction above.
預測驅動因素
CapsoVision Inc(CV)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 CV 最接近的股票,依相似度排序。
CV 季節性分析
Historically the probability of a positive September return for CV is 0.00%. December offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
CV 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Sep 2026 | $4.35 | $4.93 | $5.55 | -16.07% |
| Oct 2026 | $5.30 | $5.49 | $5.93 | -6.40% |
| Nov 2026 | $4.28 | $4.79 | $5.55 | -18.41% |
| Dec 2026 | $4.89 | $5.05 | $5.79 | -13.99% |
2026 年,CapsoVision Inc(CV)預計區間為 $4.28 至 $5.93。
CapsoVision Inc 2026 年月度預測
2026 年 Sep,CapsoVision Inc 預計均價 $4.93,最低 $4.35,最高 $5.55。
2026 年 Oct,CapsoVision Inc 預計均價 $5.49,最低 $5.30,最高 $5.93。
2026 年 Nov,CapsoVision Inc 預計均價 $4.79,最低 $4.28,最高 $5.55。
2026 年 Dec,CapsoVision Inc 預計均價 $5.05,最低 $4.89,最高 $5.79。
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。